期刊
FERTILITY AND STERILITY
卷 96, 期 4, 页码 860-U309出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2011.07.1108
关键词
IVM; non-hCG-primed; embryo vitrification; artificial endometrial priming cycle
资金
- Institute for the Promotion of Innovation by Science and Technology in Flanders [IWT 070719]
Objective: To compare clinical outcomes of fresh embryo transfer (ET) and vitrified-warmed ET in an artificial endometrial priming cycle in patients with polycystic ovaries (PCO) or polycystic ovary syndrome (PCOS) who underwent oocyte in vitro maturation (IVM) in non-hCG-primed cycles. Design: Prospective cohort study. Setting: University-based tertiary referral center. Patient(s): Thirty-nine consecutive patients <37 years old with PCO or PCOS, who underwent 73 cycles of immature oocyte retrieval. Intervention(s): Immature oocyte collection after ovarian stimulation with a cumulative dose of 450 IU uFSH or highly purified hMG, but without hCG priming. IVM of oocytes followed by ET if endometrium thickness >= 6 mm. Embryo vitrification at the cleavage stage. ET in an artificial cycle. Main Outcome Measure(s): Implantation rate (IR) and clinical pregnancy rate (CPR). Result(s): Fresh ET after IVM resulted in an IR of 6.9% (5/72) per ET and a CPR of 9.4% (5/53). ET of vitrified-warmed IVM embryos in an artificial cycle resulted in significantly better outcomes (IR 21.9% [7/32] and CPR 31.8% [7/22] per ET). Conclusion(s): A non-hCG-primed IVM system in PCO or PCOS performs poorly when embryos are transfered in a fresh cycle. Transfer of vitrified-warmed IVM embryos in an artificial cycle leads to significantly improved clinical outcomes. These data illustrate that IVM embryos in PCO or PCOS have good survival rates and suggest that hCG may be needed to support endometrial receptivity in the fresh IVM cycle. (Fertil Steril (R) 2011;96:860-4. (C) 2011 by American Society for Reproductive Medicine.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据